Pressure BioSciences, Inc.
PBIO
$0.0031
-$0.002-39.22%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.72M | -30.53M | -29.31M | -23.87M | -22.70M |
| Total Depreciation and Amortization | 221.70K | 160.10K | 112.40K | 136.10K | 113.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.07M | 21.64M | 21.88M | 17.10M | 15.23M |
| Change in Net Operating Assets | 5.00M | 4.11M | 4.14M | 3.15M | 3.56M |
| Cash from Operations | -4.43M | -4.62M | -3.19M | -3.48M | -3.80M |
| Capital Expenditure | -4.50K | -4.50K | -7.50K | -7.50K | -18.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.50K | -4.50K | -7.50K | -7.50K | -18.90K |
| Total Debt Issued | 6.06M | 7.24M | 8.25M | 9.02M | 10.05M |
| Total Debt Repaid | -1.63M | -2.90M | -5.21M | -6.01M | -6.59M |
| Issuance of Common Stock | 0.00 | 50.00K | 231.10K | 256.10K | 256.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.42M | 4.39M | 3.27M | 3.26M | 3.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.80K | -235.80K | 77.50K | -225.50K | -96.50K |